- Home
- Publications
- Publication Search
- Publication Details
Title
Sex difference in circulating PCSK9 and its clinical implications
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-07
DOI
10.3389/fphar.2022.953845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction
- (2022) Meidi Utami Puteri et al. Life-Basel
- Circulating Proprotein Convertase Subtilisin/Kexin type 9 level independently predicts incident cardiovascular events and all-cause mortality in hemodialysis black Africans patients
- (2022) François-Pantaléon Musungayi Kajingulu et al. BMC Nephrology
- Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk
- (2021) Paola G. Simeone et al. Frontiers in Aging Neuroscience
- Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
- (2021) Calvin L. Colvin et al. Journal of Clinical Lipidology
- Sex differences in outcomes for out-of-hospital cardiac arrest in the United States
- (2021) Pavitra Kotini-Shah et al. RESUSCITATION
- PCSK9 Activity Is Potentiated Through HDL Binding
- (2021) Sean A. Burnap et al. CIRCULATION RESEARCH
- Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia
- (2021) Taher A. Salaheldin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Influence of sex on survival, neurologic outcomes, and neurodiagnostic testing after out-of-hospital cardiac arrest
- (2021) Melissa A. Vogelsong et al. RESUSCITATION
- Sex differences in non-obstructive coronary artery disease
- (2020) Nida Waheed et al. CARDIOVASCULAR RESEARCH
- Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China
- (2020) Shijun Xia et al. CIRCULATION
- LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
- (2020) Peter Sever et al. European Journal of Preventive Cardiology
- 17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
- (2020) Wei Fu et al. Frontiers in Endocrinology
- Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study
- (2020) Thibaut Duparc et al. Scientific Reports
- Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
- (2020) Ik Jun Choi et al. AMERICAN JOURNAL OF CARDIOLOGY
- LEPTIN, RESISTIN, AND PCSK9 – THE ROLE OF STAT3
- (2020) Chiara Macchi et al. AMERICAN JOURNAL OF PATHOLOGY
- Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE Study
- (2020) Nicola Ferri et al. ATHEROSCLEROSIS
- Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest
- (2020) Anne Merrelaar et al. Journal of Clinical Medicine
- Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease
- (2020) Asad Shabbir et al. Annual Review of Pharmacology and Toxicology
- Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study
- (2020) Jia Peng et al. Cardiovascular Diabetology
- PCSK9 Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
- (2020) Zhiyong Qi et al. CIRCULATION
- Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry
- (2020) Ersilia M DeFilippis et al. EUROPEAN HEART JOURNAL
- An Update on the Role of PCSK9 in Atherosclerosis
- (2020) Ece Yurtseven et al. Journal of Atherosclerosis and Thrombosis
- PCSK9 rs11591147 R46L Loss‐of‐Function Variant Protects Against Liver Damage in Individuals with NAFLD
- (2020) Stefania Grimaudo et al. LIVER INTERNATIONAL
- Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk
- (2020) Cécile Ingueneau et al. VASCULAR PHARMACOLOGY
- Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study
- (2020) Jie Shi et al. Cardiovascular Diabetology
- Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population
- (2020) Hitoshi Hamamura et al. Journal of Atherosclerosis and Thrombosis
- Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
- (2019) Zhong Zhang et al. Scientific Reports
- When the Female Heart Stops: Sex and Gender Differences in Out-of-hospital Cardiac Arrest Epidemiology and Resuscitation
- (2019) Angela F. Jarman et al. CLINICAL THERAPEUTICS
- Circulating PCSK9 concentrations are increased in postmenopausal women with the metabolic syndrome
- (2019) Nutjaree Jeenduang CLINICA CHIMICA ACTA
- Resveratrol downregulates PCSK9 expression and attenuates steatosis through estrogen receptor α-mediated pathway in L02 cells
- (2019) Yi Jing et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sex Differences in the Use of Statins in Community Practice
- (2019) Michael G. Nanna et al.
- PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
- (2019) Yunes Panahi et al. CLINICAL BIOCHEMISTRY
- Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines
- (2019) Shijie Liu et al. CARDIOVASCULAR RESEARCH
- Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
- (2019) Peter R Sinnaeve et al. EUROPEAN HEART JOURNAL
- Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 Ameliorates Liver Fibrosis via Mitigation of Intestinal Endotoxemia
- (2019) Yanting Zou et al. INFLAMMATION
- Sex differences in cardiometabolic disorders
- (2019) Eva Gerdts et al. NATURE MEDICINE
- Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes
- (2019) Stéphane Ramin-Mangata et al. ATHEROSCLEROSIS
- Female reproductive history and risk of type 2 diabetes: A prospective analysis of 126 721 women
- (2018) Nirmala Pandeya et al. DIABETES OBESITY & METABOLISM
- PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?
- (2018) Massimo R. Mannarino et al. Journal of Clinical Lipidology
- PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
- (2018) A. Liu et al. JOURNAL OF INTERNAL MEDICINE
- Gender differences in glucose homeostasis and diabetes
- (2018) Franck Mauvais-Jarvis PHYSIOLOGY & BEHAVIOR
- Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study
- (2018) Basmah Safdar et al. Journal of the American Heart Association
- Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
- (2018) Kwi-Hyun Bae et al. Diabetes & Metabolism Journal
- The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia
- (2018) Ye-Xuan Cao et al. ATHEROSCLEROSIS
- Gender difference of symptoms of acute coronary syndrome among Chinese patients: a cross-sectional study
- (2018) Libin An et al. European Journal of Cardiovascular Nursing
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies
- (2017) Christian M. Madsen et al. EUROPEAN HEART JOURNAL
- Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials
- (2017) Ioanna Kosmidou et al. EUROPEAN HEART JOURNAL
- Clinical characteristics and prognosis of acute coronary syndrome in young women and men: A systematic review and meta-analysis of prospective studies
- (2017) Qinghua Ma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
- (2017) Eliano P. Navarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors
- (2017) Jacqueline A Krysa et al. JOURNAL OF NUTRITION
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
- (2017) Amy E. Levenson et al. PEDIATRIC DIABETES
- Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease
- (2017) Valentin Schlegel et al. PLoS One
- Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation)
- (2017) Tanya S. Kenkre et al. Circulation-Cardiovascular Quality and Outcomes
- Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity
- (2017) Sha Li et al. Scientific Reports
- Liver fat accumulation is associated with circulating PCSK9
- (2016) Massimiliano Ruscica et al. ANNALS OF MEDICINE
- PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
- (2016) Nicola Ferri et al. ATHEROSCLEROSIS
- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort
- (2016) Robert W. McGarrah et al. ATHEROSCLEROSIS
- Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9)
- (2016) Yu Wang et al. Cardiovascular Diabetology
- Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study
- (2016) Dean G. Karalis et al. Journal of Clinical Lipidology
- Acute coronary syndromes in women and men
- (2016) Neha J. Pagidipati et al. Nature Reviews Cardiology
- Associations between gender and cardiac arrest outcomes in Pan-Asian out-of-hospital cardiac arrest patients
- (2016) Yih Yng Ng et al. RESUSCITATION
- Sex-Based Differences in Acute Coronary Syndromes
- (2016) Jaya Chandrasekhar et al. JACC-Cardiovascular Imaging
- Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease
- (2015) Sha Li et al. ANNALS OF MEDICINE
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Sex differences in coronary artery disease: Pathological observations
- (2015) Kazuyuki Yahagi et al. ATHEROSCLEROSIS
- Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
- (2015) Xin-Lin Zhang et al. BMC Medicine
- Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans
- (2015) T.C. Ooi et al. CLINICA CHIMICA ACTA
- Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
- (2015) A. Sahebkar et al. DIABETES OBESITY & METABOLISM
- Prognostic value of PCSK9 levels in patients with acute coronary syndromes
- (2015) Baris Gencer et al. EUROPEAN HEART JOURNAL
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
- (2015) EUROPEAN HEART JOURNAL
- β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells
- (2015) Amanda E. Starr et al. FEBS Journal
- PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice
- (2015) Anna Roubtsova et al. JOURNAL OF LIPID RESEARCH
- Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease
- (2015) Vera Bittner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease
- (2015) Jian-Jun Li et al. MEDICINE
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
- (2014) Moumita Ghosh et al. JOURNAL OF LIPID RESEARCH
- Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment
- (2014) Christian Werner et al. VASCULAR PHARMACOLOGY
- Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease
- (2013) Tara L. Sedlak et al. AMERICAN HEART JOURNAL
- Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation
- (2013) Tanja Kosenko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous Estrogens Lower Plasma PCSK9 and LDL Cholesterol But Not Lp(a) or Bile Acid Synthesis in Women
- (2011) Lena Persson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
- (2010) Lena Persson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Women's Health Initiative Hormone Trials) † ‡
- (2008) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now